Related Experiment Video
Updated: Jul 17, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
Antibiotic treatment of infective endocarditis
Abstract:
At least 85% of patients with infective endocarditis can be cured with effective therapy. Streptococci or staphylococci cause 75% of cases of endocarditis. Patients with penicillin-sensitive viridans or nonenterococcal group D streptococcal endocarditis may be treated successfully with aqueous penicillin G alone for four weeks or with combined penicillin and streptomycin for two weeks. Enterococcal endocarditis should be treated for four to six weeks with a combination of aqueous penicillin G together with either streptomycin or gentamicin. Patients with endocarditis caused by Staphylococcus aureus should receive antimicrobial therapy for four to six weeks with a semisynthetic penicillin (nafcillin or oxacillin) or a cephalosporin such as cephalothin or cefazolin. In urgent cases where empiric antimicrobial therapy is necessary before the causative organism is identified, a combination of aqueous penicillin G, nafcillin, and gentamicin is effective therapy.
Insights
Effective therapy cures over 85% of infective endocarditis cases. Treatment varies by bacteria, with specific antibiotic regimens for streptococci and staphylococci infections.
Area of Science:
- Infectious Diseases
- Cardiology
- Pharmacology
Background:
- Infective endocarditis is a serious infection of the heart lining.
- Streptococci and staphylococci are the most common causative agents, accounting for 75% of cases.
- Successful treatment relies on accurate diagnosis and appropriate antimicrobial therapy.
Purpose of the Study:
- To outline effective therapeutic strategies for infective endocarditis.
- To detail antibiotic choices based on specific bacterial pathogens.
- To provide guidance on empiric therapy for urgent cases.
Main Methods:
- Review of established treatment protocols for infective endocarditis.
- Categorization of treatment regimens by causative organism (Streptococci, Staphylococci).
- Identification of recommended antibiotic classes and durations for various endocarditis types.
Main Results:
- Penicillin-sensitive viridans or nonenterococcal group D streptococcal endocarditis: treated with aqueous penicillin G for 4 weeks or penicillin/streptomycin for 2 weeks.
- Enterococcal endocarditis: treated with aqueous penicillin G plus streptomycin or gentamicin for 4-6 weeks.
- Staphylococcus aureus endocarditis: treated with nafcillin, oxacillin, cephalothin, or cefazolin for 4-6 weeks.
- Empiric therapy for unidentified organisms: aqueous penicillin G, nafcillin, and gentamicin combination.
Conclusions:
- Infective endocarditis is highly curable with appropriate antimicrobial therapy, achieving cure rates over 85%.
- Tailoring antibiotic treatment to the specific causative microorganism is crucial for successful outcomes.
- A combination of aqueous penicillin G, nafcillin, and gentamicin provides effective empiric therapy when the pathogen is unknown.
Related Concept Videos
Mitral Stenosis III: Medical Management
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Myocarditis III: Medical Management

